EN | TR
E-ISSN: 3061-9947
Roux En-Y Type Gastric Bypass Long-Term Results and Effects on Concomitant Diseases in the Treatment of Morbid Obesity; Infancy of Morbid Obesity Surgery
PDF
Cite
Share
Request
Original Article
VOLUME: 54 ISSUE: 1
P: 23-30
2021

Roux En-Y Type Gastric Bypass Long-Term Results and Effects on Concomitant Diseases in the Treatment of Morbid Obesity; Infancy of Morbid Obesity Surgery

Acta Haematol Oncol Turc 2021;54(1):23-30
DOI: 10.5505/aot.2021.94834
Ergün Yüksel 1
Mehmet Akif Üstüner 2
Mehmet Mihmanlı 3
1. General Surgery Clinic, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey
2. Gastroenterology Surgery Clinic, University of Health Sciences Gülhane Training and Research Hospital, Ankara, Turkey
3. General Surgery Clinic, University of Health Sciences Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
4.
No information available.
No information available
Received Date: 2020-06-21T23:41:29
Accepted Date: 2021-04-07T09:21:09
PDF
Cite
Share
Request

Abstract

INTRODUCTION

Morbid obesity is a multifactorial disease that is a major health problem all over the world. In this study, we presented the first two-year follow-up of patients who underwent conventional Roux En-Y Type Gastric Bypass (RYGB) performed in the years when obesity surgery has just begun in our country.

METHODS

In our study, pre-and post-operative data of 15 patients who underwent RGYB due to morbid obesity.

RESULTS

The data of 15 patients, 6 male (40%) and 9 female (60%), were evaluated in the study. The mean age of the patients was 38 ± 12.90 (24-63) years in all cases and 31.5 ± 8.16 (24-46) years in men and 42.33 ± 14.02 (26-63) years in women. In the preoperative evaluation of patients in terms of concomitant diseases, it was determined that 47% of the patients had HT (n = 7), 20% (n = 3) Type II DM, 6.67% (n = 1) hypermenorrhea, 6.67% (n = 1) venous ulcers in the lower extremity, 13.34% (n = 2) menstrual cycle irregularity, 6.67% (n = 1) UAS, 6.67% (n = 1) chronic obstructive pulmonary disease (COPD), 20% (n = 3) Hepatosteatosis.

DISCUSSION AND CONCLUSION

Conventional RYGB surgery is one of the first morbid obesity surgeries performed in our country. It is a safe method in the treatment of morbid obesity, which enables patients to lose weight and at the same time to recover from obesity induced by comorbid diseases, and causes a significant change in the quality of life of patients.